Asian Spectator

Men's Weekly

.

Positive Phase III Clinical Results for EirGenix's Proposed Tr...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
TAIPEI, March 23, 2021 /PRNewswire-AsiaNet/ -- In a press conference today, EirGenix, Inc. (6589.TT) announced that the Phase III clinical trial (Trial No.: EGC002, NCT03433313) of its breast cancer biosimilar, EG12014 (proposed trastuzumab biosimilar, also called EGI014), has met its primary ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Female genital cutting: why Southeast Asia should follow Africa’s lead in challenging religious and cultural justifications

Illustration of campaign against Female Genital Mutilation (FGM).Tunatura/ShutterstockFemale genital mutilation or cutting (FGM/C) remains a threat to the rights of women in Southeast Asia, often reli...

Manfaat tempe juga bisa menyehatkan tulang: Mengapa pengakuan dari UNESCO saja tidak cukup?

● Sejumlah negara (seperti Belgia dan Jepang) merekomendasikan warganya memperbanyak konsumsi tempe. ● Tempe punya banyak manfaat kesehatan, termasuk bagi kesehatan tulang.● Pemerint...

Pemberdayaan warga jadi solusi efektif meredam abrasi: Pelajaran dari pesisir Bulukumba

● Indonesia memiliki banyak kawasan pesisir rawan abrasi ekstrem, seperti di Bulukumba, Sulawesi Selatan.● Pemberdayaan masyarakat setempat amat krusial untuk mencegah abrasi.● Pemba...